LOXO ONCOLOGY INC's ticker is LOXO and the CUSIP is 548862101. A total of 130 filers reported holding LOXO ONCOLOGY INC in Q2 2017. The put-call ratio across all filers is 2.66 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $50,425,000 | -18.0% | 360,000 | 0.0% | 8.63% | +15.4% |
| Q3 2018 | $61,499,000 | -6.7% | 360,000 | -5.3% | 7.48% | -18.9% |
| Q2 2018 | $65,923,000 | +58.7% | 380,000 | +5.6% | 9.22% | +26.2% |
| Q1 2018 | $41,533,000 | +37.0% | 360,000 | 0.0% | 7.30% | -1.0% |
| Q4 2017 | $30,305,000 | -8.6% | 360,000 | 0.0% | 7.38% | -21.2% |
| Q3 2017 | $33,163,000 | +14.9% | 360,000 | 0.0% | 9.36% | -12.3% |
| Q2 2017 | $28,868,000 | +90.6% | 360,000 | 0.0% | 10.68% | +19.5% |
| Q1 2017 | $15,149,000 | +31.0% | 360,000 | 0.0% | 8.94% | -6.4% |
| Q4 2016 | $11,561,000 | +51.8% | 360,000 | +23.7% | 9.55% | +54.8% |
| Q3 2016 | $7,618,000 | +9.5% | 291,000 | -3.0% | 6.17% | -10.9% |
| Q2 2016 | $6,954,000 | +1.7% | 300,000 | +20.0% | 6.92% | -11.8% |
| Q1 2016 | $6,835,000 | -4.5% | 250,000 | -0.6% | 7.84% | +24.1% |
| Q4 2015 | $7,155,000 | – | 251,500 | – | 6.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital LLC | 3,438,920 | $289,488,000 | 57.19% |
| DAFNA Capital Management LLC | 296,000 | $24,917,000 | 13.42% |
| Casdin Capital, LLC | 360,000 | $30,305,000 | 7.38% |
| Opaleye Management Inc. | 176,300 | $14,841,000 | 4.75% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 574,495 | $48,361,000 | 1.84% |
| SECTORAL ASSET MANAGEMENT INC | 152,185 | $12,811,000 | 1.60% |
| AWM Investment Company, Inc. | 85,000 | $7,155,000 | 1.39% |
| Eventide Asset Management | 285,000 | $23,991,000 | 1.25% |
| Rock Springs Capital Management LP | 310,000 | $26,096,000 | 1.18% |
| Crawford Lake Capital Management, LLC | 53,420 | $4,497,000 | 1.06% |